eIF4A inhibition allows translational regulation of mRNAs encoding proteins involved in Alzheimer's Disease

PLoS ONE

Volumn 5, Issue 9, 2010, Pages

  Bottley, Andrew ^a   Phillips, Nicola M ^a   Webb, Thomas E ^a   Willis, Anne E ^a   Spriggs, Keith A ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; MESSENGER RNA; TAU PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ELF 4A; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ALZHEIMER DISEASE; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; TRANSLATION REGULATION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; CELL LINE; DOWN-REGULATION; EUKARYOTIC INITIATION FACTORS; HUMANS; OXIDATIVE STRESS; PROTEIN BIOSYNTHESIS; RNA, MESSENGER; TAU PROTEINS;

EID: 77958553800     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013030     Document Type: Article

References (53)

1. Small SA, Duff K (2008) Linking Abeta and tau in late-onset Alzheimer's disease: a dual pathway hypothesis. Neuron 60: 534-542.
2. Rogers JT, Randall JD, Eder PS, Huang X, Bush AI, et al. (2002) Alzheimer's disease drug discovery targeted to the APP mRNA 5'untranslated region. J Mol Neurosci 19: 77-82.
3. Payton S, Cahill CM, Randall JD, Gullans SR, Rogers JT (2003) Drug discovery targeted to the Alzheimer's APP mRNA 59-untranslated region: the action of paroxetine and dimercaptopropanol. J Mol Neurosci 20: 267-275.
4. Biran Y, Masters CL, Barnham KJ, Bush AI, Adlard PA (2009) Pharmacotherapeutic targets in Alzheimer's disease. J Cell Mol Med 13: 61-86.
5. Le Corre S, Klafki HW, Plesnila N, Hubinger G, Obermeier A, et al. (2006) An inhibitor of tau hyperphosphorylation prevents severe motor impairments in tau transgenic mice. Proc Natl Acad Sci U S A 103: 9673-9678.
6. Morse LJ, Payton SM, Cuny GD, Rogers JT (2004) FDA-preapproved drugs targeted to the translational regulation and processing of the amyloid precursor protein. J Mol Neurosci 24: 129-136.
7. van Marum RJ (2008) Current and future therapy in Alzheimer's disease. Fundam Clin Pharmacol 22: 265-274.
8. Yan P, Bero AW, Cirrito JR, Xiao Q, Hu X, et al. (2009) Characterizing the appearance and growth of amyloid plaques in APP/PS1 mice. J Neurosci 29: 10706-10714.
9. Roberson ED, Scearce-Levie K, Palop JJ, Yan F, Cheng IH, et al. (2007) Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science 316: 750-754.
10. Butterfield DA, Reed T, Newman SF, Sultana R (2007) Roles of amyloid betapeptide- associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment. Free Radic Biol Med 43: 658-677.
11. Pratico D (2008) Oxidative stress hypothesis in Alzheimer's disease: a reappraisal. Trends Pharmacol Sci 29: 609-615.
12. Lovell MA, Markesbery WR (2007) Oxidative damage in mild cognitive impairment and early Alzheimer's disease. J Neurosci Res 85: 3036-3040.
13. Nunomura A, Perry G, Aliev G, Hirai K, Takeda A, et al. (2001) Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 60: 759-767.
14. Butterfield DA, Drake J, Pocernich C, Castegna A (2001) Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide. Trends Mol Med 7: 548-554.
15. Butterfield DA, Griffin S, Munch G, Pasinetti GM (2002) Amyloid beta-peptide and amyloid pathology are central to the oxidative stress and inflammatory cascades under which Alzheimer's disease brain exists. J Alzheimers Dis 4: 193-201.
16. Rhein V, Song X, Wiesner A, Ittner LM, Baysang G, et al. (2009) Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice. Proc Natl Acad Sci U S A 106: 20057-20062.
17. Beaudoin ME, Poirel VJ, Krushel LA (2008) Regulating amyloid precursor protein synthesis through an internal ribosomal entry site. Nucleic Acids Res 36: 6835-6847.
18. Veo BL, Krushel LA (2009) Translation initiation of the human tau mRNA through an internal ribosomal entry site. J Alzheimers Dis 16: 271-275.
19. Spriggs KA, Cobbold LC, Jopling CL, Cooper RE, Wilson LA, et al. (2009) Canonical initiation factor requirements of the Myc family of internal ribosome entry segments. Mol Cell Biol 29: 1565-1574.
20. Lahiri DK, Ge YW, Maloney B (2005) Characterization of the APP proximal promoter and 59-untranslated regions: identification of cell type-specific domains and implications in APP gene expression and Alzheimer's disease. FASEB J 19: 653-655.
21. Bordeleau ME, Mori A, Oberer M, Lindqvist L, Chard LS, et al. (2006) Functional characterization of IRESes by an inhibitor of the RNA helicase eIF4A. Nat Chem Biol 2: 213-220.
22. Harris SE, Fox H, Wright AF, Hayward C, Starr JM, et al. (2007) A genetic association analysis of cognitive ability and cognitive ageing using 325 markers for 109 genes associated with oxidative stress or cognition. BMC Genet 8: 43.
23. Iadecola C, Zhang F, Niwa K, Eckman C, Turner SK, et al. (1999) SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein. Nat Neurosci 2: 157-161.
24. Masutani H, Bai J, Kim YC, Yodoi J (2004) Thioredoxin as a neurotrophic cofactor and an important regulator of neuroprotection. Mol Neurobiol 29: 229-242.
25. Sonenberg N, Hinnebusch AG (2009) Regulation of translation initiation in eukaryotes: mechanisms and biological targets. Cell 136: 731-745.
26. Mignone F, Gissi C, Liuni S, Pesole G (2002) Untranslated regions of mRNAs. Genome Biol 3: REVIEWS0004.
27. Svitkin YV, Pause A, Haghighat A, Pyronnet S, Witherell G, et al. (2001) The requirement for eukaryotic initiation factor 4A (elF4A) in translation is in direct proportion to the degree of mRNA 59 secondary structure. RNA 7: 382-394.
28. Daga RR, Jimenez J (1999) Translational control of the cdc25 cell cycle phosphatase: a molecular mechanism coupling mitosis to cell growth. J Cell Sci 112 Pt 18: 3137-3146.
29. Jansen AP, Camalier CE, Colburn NH (2005) Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis. Cancer Res 65: 6034-6041.
30. Jin H, Kim TH, Hwang SK, Chang SH, Kim HW, et al. (2006) Aerosol delivery of urocanic acid-modified chitosan/programmed cell death 4 complex regulated apoptosis, cell cycle, and angiogenesis in lungs of K-ras null mice. Mol Cancer Ther 5: 1041-1049.
31. Lin JC, Hsu M, Tarn WY (2007) Cell stress modulates the function of splicing regulatory protein RBM4 in translation control. Proc Natl Acad Sci U S A 104: 2235-2240.
32. Davuluri RV, Suzuki Y, Sugano S, Zhang MQ (2000) CART classification of human 59 UTR sequences. Genome Res 10: 1807-1816.
33. Wang H, Iacoangeli A, Popp S, Muslimov IA, Imataka H, et al. (2002) Dendritic BC1 RNA: functional role in regulation of translation initiation. J Neurosci 22: 10232-10241.
34. Mus E, Hof PR, Tiedge H (2007) Dendritic BC200 RNA in aging and in Alzheimer's disease. Proc Natl Acad Sci U S A 104: 10679-10684.
35. Fukao A, Sasano Y, Imataka H, Inoue K, Sakamoto H, et al. (2009) The ELAV Protein HuD Stimulates Cap-Dependent Translation in a Poly(A)- and eIF4ADependent Manner. Molecular Cell 36: 10.
36. An J, Yuan Q, Wang C, Liu L, Tang K, et al. (2005) Differential display of proteins involved in the neural differentiation of mouse embryonic carcinoma P19 cells by comparative proteomic analysis. Proteomics 5: 1656-1668.
37. Morgan R, Sargent MG (1997) The role in neural patterning of translation initiation factor eIF4AII; induction of neural fold genes. Development 124: 2751-2760.
38. Ponten F, Jirstrom K, Uhlen M (2008) The Human Protein Atlas-a tool for pathology. J Pathol 216: 387-393.
39. Giorgi C, Yeo GW, Stone ME, Katz DB, Burge C, et al. (2007) The EJC factor eIF4AIII modulates synaptic strength and neuronal protein expression. Cell 130: 179-191.
40. Li Q, Imataka H, Morino S, Rogers GW, Jr., Richter-Cook NJ, et al. (1999) Eukaryotic translation initiation factor 4AIII (eIF4AIII) is functionally distinct from eIF4AI and eIF4AII. Mol Cell Biol 19: 7336-7346.
41. Morel M, Couturier J, Lafay-Chebassier C, Paccalin M, Page G (2009) PKR, the double stranded RNA-dependent protein kinase as a critical target in Alzheimer's disease. J Cell Mol Med 13: 1476-1488.
42. Resende R, Ferreiro E, Pereira C, Oliveira CR (2008) ER stress is involved in Abeta-induced GSK-3beta activation and tau phosphorylation. J Neurosci Res 86: 2091-2099.
43. O'Connor T, Sadleir KR, Maus E, Velliquette RA, Zhao J, et al. (2008) Phosphorylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogenesis. Neuron 60: 988-1009.
44. Haugabook SJ, Le T, Yager D, Zenk B, Healy BM, et al. (2001) Reduction of Abeta accumulation in the Tg2576 animal model of Alzheimer's disease after oral administration of the phosphatidyl-inositol kinase inhibitor wortmannin. FASEB J 15: 16-18.
45. Celsi F, Ferri A, Casciati A, D'Ambrosi N, Rotilio G, et al. (2004) Overexpression of superoxide dismutase 1 protects against beta-amyloid peptide toxicity: effect of estrogen and copper chelators. Neurochem Int 44: 25-33.
46. Turner BJ, Li QX, Laughton KM, Masters CL, Lopes EC, et al. (2004) Brain beta-amyloid accumulation in transgenic mice expressing mutant superoxide dismutase 1. Neurochem Res 29: 2281-2286.
47. Akterin S, Cowburn RF, Miranda-Vizuete A, Jimenez A, Bogdanovic N, et al. (2006) Involvement of glutaredoxin-1 and thioredoxin-1 in beta-amyloid toxicity and Alzheimer's disease. Cell Death Differ 13: 1454-1465.
48. Brink TC, Demetrius L, Lehrach H, Adjaye J (2009) Age-related transcriptional changes in gene expression in different organs of mice support the metabolic stability theory of aging. Biogerontology 10: 549-564.
49. Yeh CH, Pang JH, Wu YC, Wang YC, Chu JJ, et al. (2004) Differential-display polymerase chain reaction identifies nicotinamide adenine dinucleotideubiquinone oxidoreductase as an ischemia/reperfusion-regulated gene in cardiomyocytes. Chest 125: 228-235.
50. Abramoff MD, Magelhaes PJ, Ram SJ (2004) Image Processing with ImageJ. Biophotonics International 11: 36-42.
51. Lesne S, Koh MT, Kotilinek L, Kayed R, Glabe CG, et al. (2006) A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440: 352-357.
52. Stoneley M, Chappell SA, Jopling CL, Dickens M, MacFarlane M, et al. (2000) c-Myc protein synthesis is initiated from the internal ribosome entry segment during apoptosis. Mol Cell Biol 20: 1162-1169.
53. Sisodia SS (1992) Beta-amyloid precursor protein cleavage by a membranebound protease. Proc Natl Acad Sci U S A 89: 6075-6079.